🇺🇸 FDA
Patent

US 7678764

Protein formulations for use at elevated temperatures

granted A61KA61K38/1875A61K47/18

Quick answer

US patent 7678764 (Protein formulations for use at elevated temperatures) held by JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC
Grant date
Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/1875, A61K47/18, A61K47/183, A61K47/20